Administration of Activated Charcoal or Sodium Polystyrene Sulfonate (KayexalateTM) as Gastric Decontamination for Lithium Intoxication: An Animal Model-Reference-Cited by-同舟云学术

Administration of Activated Charcoal or Sodium Polystyrene Sulfonate (KayexalateTM) as Gastric Decontamination for Lithium Intoxication: An Animal Model

Published:1989-11 Issue:5 Volume:65 Page:387-389
ISSN:0901-9928
Container-title:Pharmacology & Toxicology
language:en
Short-container-title:

Author:

Linakis James G.,Lacouture Peter G.,Eisenberg Marc S.,Maher Timothy J.,Lewander William J.,Driscoll James L.,Woolf Alan D.

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0773.1989.tb01194.x/fullpdf

Reference7 articles.

1. Acceleration of the body clearance of phenobarbital by oral activated charcoal;Berg;New Engl. J. Med.,1982

2. Enhancement of theophylline clearance by oral activated charcoal;Berlinger;Clin. Pharmacol. Therap.,1983

3. In vitro study of lithium carbonate adsorption by activated charcoal;Favin;J. Toxicol. Clin. Toxicol.,1988

4. In vitro binding of Li+ ion using a clinical cation exchange resin (KayexalateTM);Gehrke;Ann. Emerg. Med.,1986

5. Role of repeated oral doses of activated charcoal in clinical toxicology;Pond;Med. Toxicol.,1986

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review on the use of activated charcoal for gastrointestinal decontamination following acute oral overdose;Clinical Toxicology;2021-08-23

2. In-vitro study of lithium binding by sodium zirconium cyclosilicate (Lokelma®) or patiromer (Veltassa®);Toxicology Communications;2021-01-01

3. Lithium Toxicity from the Addition of an ACE Inhibitor with an Unexpected Type I Brugada Pattern ECG: Case Files of the Medical Toxicology Fellowship at the University of California, San Diego;Journal of Medical Toxicology;2020-04-15

4. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA;Nano Letters;2018-04-25

5. Syndrome de neurotoxicité irréversible de lithium-effectuated ou SILENT : à propos d’un cas;Therapies;2017-06